Publications:127
Video Visit Available
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Emily J Gallagher, MD, PhD
Emily Jane Gallagher (Preferred Name)
Endocrine, Diabetes and Bone Diseases (Endocrinology)
About Me
Dr. Emily J. Gallagher is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Disease and Associate Program Director of the Internal Medicine Residency Program. She is also the Director of the Research Track for the Internal Medicine Residency Program.
Dr. Gallagher earned her MB BCh BAO (MD equivalent) with honors from University College Dublin, Ireland and her PhD in Physiology and Medical Physics from the Royal College of Surgeons of Ireland. She is Board Certified in Internal Medicine and Endocrinology and is a Member of the Royal College of Physicians of Ireland (MRCPI). Dr. Gallagher trained in Internal Medicine and Endocrinology at the Mater Miseriordiae University Hospital, Dublin, and completed her postgraduate training in Internal Medicine and Endocrinology at Mount Sinai. She was Chief Fellow in Endocrinology, and was subsequently appointed Assistant Professor of Medicine Endocrinology, Diabetes and Bone Diseases.
She has been Principle Investigator on an Endocrine Fellows Foundation, Fellows Development Research Grant, and a K08 Clinician-Scientist Career Development Award from the NIH / NCI to study the role of hyperlipidemia in breast cancer progression. Dr. Gallagher is co-investigator on a number of NIH-funded studies. She has received a Tisch Cancer Institute at Mount Sinai Junior Scientist Research Award, a Mount Sinai Department of Medicine Junior Faculty Translational Collaborative Research Pilot Award and the Harold and Golden Lamport Research Award.
Dr. Gallagher’s clinical practice is in the field of onco-endocrinology: the management of endocrine and metabolic complications of cancer and its treatments. These complications of oncology treatments include: type 1 and type 2 diabetes drug induced hyperglycemia; dyslipidemia; complications of targeted therapies, small molecule inhibitors and immune checkpoint inhibitors that affect the pancreas, thyroid, pituitary and adrenal glands.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
Clinical Focus
- Diabetes
- Hyperlipidemia
- Hypopituitarism
- Obesity
- Thyroid Diseases
- Type 1 Diabetes
- Type 2 Diabetes
Video
Education
MD, University College Dublin
Fellowship, Mater Misericordiae University Hospital
MD, University College Dublin
MRCPI, Royal College of Physicians
PhD, Royal College of Surgeons
Residency, Mater Misericordiae University Hospital
Residency, Internal Medicine
Mater Misericordiae University Hospital
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Endocrinology, Diabetes and Metabolism
Mater Misericordiae University Hospital
Fellowship, Endocrinology, Diabetes and Metabolism
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Research
Please visit the Gallagher Laboratory at https://labs.icahn.mssm.edu/gallagherlab/
A complete list of publications can be found at https://www.ncbi.nlm.nih.gov/sites/myncbi/1f1gDxyoohx5v/bibliography/48238446/public/
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) please click here for more information. Patients with Molina insurance should click here for more information. Mount Sinai’s contracts with Anthem and Molina expired on December 31.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. Ling Zhu, Yee Ming M. Cheung, Cherie Chiang, Emily J. Gallagher, Ole Petter R. Hamnvik, Jennifer Mammen, Zoe Quandt, Renisha Jones, Jon McDunn, Huda Al-Bahadili, Trevor Angell, Irina Bancos, Allison Betof Warner, Susan Blackwell, Cassandra Calabrese, Tracey A. Cho, Michael Dougan, Michelle Ferreira, Pauline Funchain, Justine Herndon, Douglas B. Johnson, Randol Kennedy, Meenal Kheterpal, Michel Khouri, Melissa G. Lechner, Annette M. Lim, Alina Markova, Alexa Meara, Laura Overton, Ana Luisa Perdigoto, Nirupa Sachithanandan, Elad Sharon, Lavinia Spain, Katy Tsai, Mark Yarchoan, Kerry L. Reynolds, Afreen Shariff. Journal for ImmunoTherapy of Cancer
- Impacts of climate change on cancer risk, clinical outcomes, and care delivery: A scoping review. D. Larios, T. Jayakrishnan, M. Ioakeim Ioannidou, J. Lewy, E. Woodworth, E. Gallagher, C. Mita, A. Ivanov, A. C. Duhaime, A. Hantel. Journal of Climate Change and Health
- An insider’s guide to understanding and obtaining an NIH K career development award. Don C. Rockey, Kyu Y. Rhee, Christopher S. Williams, Jatin M. Vyas, Charles W. Emala, Emily J. Gallagher. JCI insight
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.8 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.8 out of 5
Always always professional and courteous.
Dr. Gallagher is an excellent physician, she listened to what I had to say and was engaged in conversation to subject matter. Explanations were very well for my level of understanding and very thorough. There is nothing more a doctor could do for a patient!
I have a profound appreciation and unyielding gratitude for the staff at Mount Sinai Hospital for saving my life on numerous occasions.Dr. Emily Gallagher is a brilliant and thoughtful physician. In my view, she is an excellent representation of the level of patient care, In which all aspects of my health are addressed in a manner that leaves me feeling informed, less anxious and feeling valued.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gallagher during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Reactive Biosciences
- SynDevRx
- Irish Clinical Academic Training (ICAT) Programme
- Novartis Pharmaceutical Corporation
- Flare Therapeutics
- SignifyMD
- German Federal Ministry of Education and Research
- Seagen
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.